PSC Biotech Ltd Revenue and Competitors
Estimated Revenue & Valuation
- PSC Biotech Ltd's estimated annual revenue is currently $1.9M per year.
- PSC Biotech Ltd's estimated revenue per employee is $155,000
Employee Data
- PSC Biotech Ltd has 12 Employees.
- PSC Biotech Ltd grew their employee count by 0% last year.
PSC Biotech Ltd's People
Name | Title | Email/Phone |
---|
PSC Biotech Ltd Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $14.4M | 93 | 41% | N/A | N/A |
#2 | $8.4M | 72 | 44% | $166M | N/A |
#3 | $1.9M | 12 | 0% | N/A | N/A |
#4 | $1.4M | 9 | 0% | N/A | N/A |
#5 | $13.6M | 88 | 49% | N/A | N/A |
What Is PSC Biotech Ltd?
Founded in 1996, PSC Biotech Corporation was created with the vision of providing life science companies unmatched support. To date, PSC Biotech Corporation now serves 350 clients in more than 23 countries worldwide through professional services consulting with Ireland being established in 2011 followed by the UK. PSC are a, cloud-based software solutions, pharmaceuticals contract manufacturing, life science investment consulting, and metrology services company. PSC Biotech Corporation has six unique divisions within the parent company – each representing one of our areas of expertise: PSC Biotech, PSC Software, BioTechnique™, PSC Partners, PSC Metrology and PSC Investments. Additionally, PSC Asia and PSC Biotech Ltd represent PSC Biotech Corporation in Asia and Europe, respectively. Together, these divisions enable us to meet the ever-changing needs of our clients with a commitment to excellence and superior quality. To learn more, visit www.biotech.com.
keywords:N/AN/A
Total Funding
12
Number of Employees
$1.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 14 | 8% | N/A |
#2 | $7.3M | 56 | 0% | N/A |
#3 | $23.2M | 129 | 18% | N/A |
#4 | $46.4M | 196 | 13% | N/A |
#5 | $40M | 251 | N/A | N/A |